Cardinal Health, Inc. CAH
273.72 USD +2.00 (+0.74%)
Nov 9, 2026, 11:17 AM EST
272.56 Day range 277.38
180.45 52-week range 286.29
- YTD
- +33.20%
- 1 year
- +34.39%
News
benzinga.com TD Cowen Maintains Buy on Cardinal Health, Raises Price Target to $304 TD Cowen analyst Charles Rhyee maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $280 to $304.
marketbeat.com Cardinal Health Q1 Earnings Call Highlights Cardinal Health NYSE: CAH raised its fiscal 2027 earnings outlook after reporting double-digit profit growth in its pharmaceutical and specialty segment and its other growth businesses for the first…
benzinga.com RBC Capital Maintains Outperform on Cardinal Health, Raises Price Target to $295 RBC Capital analyst Ryan Halsted maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price target from $276 to $295.
benzinga.com Evercore ISI Group Maintains Outperform on Cardinal Health, Raises Price Target to $320 Evercore ISI Group analyst Elizabeth Anderson maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price target from $270 to $320.
defenseworld.net Cardinal Health (NYSE:CAH) Hits New 12-Month High Following Earnings Beat Shares of Cardinal Health, Inc. (NYSE: CAH - Get Free Report) reached a new 52-week high during trading on Thursday following a better than expected earnings announcement. The company traded as high…
benzinga.com Cardinal Health Sees Healthy Demand, Despite Modest Commodity Pressure Cardinal Health tops Q1 2027 estimates, and raises guidance, as robust pharma sales offset petroleum headwinds in medical distribution.
benzinga.com Nasdaq Tumbles 4.5%; Cardinal Health Shares Gain After Upbeat Q1 Earnings U.S. stocks tumbled: Nasdaq -4.5%, S&P 500 -3.3%, Dow -2.5%. Cardinal Health rose on strong results; AppLovin surged 32%, while Veracyte fell 55%.
benzinga.com Cardinal Health Q1 2027 Earnings Call Transcript Cardinal Health (NYSE:CAH) reported first-quarter financial results on Thursday. The transcript from the company’s first-quarter earnings call has been provided below.This transcript is brought to…
zacks.com Cardinal Health (CAH) Q1 Earnings and Revenues Top Estimates Cardinal Health (CAH) came out with quarterly earnings of $3.26 per share, beating the Zacks Consensus Estimate of $2.92 per share. This compares to earnings of $2.55 per share a year ago.
benzinga.com Cardinal Health Q1 Adj. EPS $3.26 Beats $2.94 Estimate, Sales $67.513B Beat $66.588B Estimate Cardinal Health (NYSE:CAH) reported quarterly earnings of $3.26 per share which beat the analyst consensus estimate of $2.94 by 10.88 percent. This is a 27.84 percent increase over earnings of $2.55…
benzinga.com Cardinal Health Raises FY2027 Adj EPS Guidance from $12.40-$12.60 to $12.80-$13.00 vs $12.56 Est Cardinal Health (NYSE:CAH) raises FY2027 Adj EPS guidance from $12.40-$12.60 to $12.80-$13.00 vs $12.56 analyst estimate..
prnewswire.com Cardinal Health Reports First Quarter Fiscal Year 2027 Results and Raises Outlook First quarter revenue increased 5% to $67.5 billion GAAP 1 operating earnings increased 13% to $753 million; GAAP diluted EPS increased 27% to $2.38 Non-GAAP operating earnings increased 17% to $1.0…
benzinga.com Top Wall Street Forecasters Revamp Cardinal Health Expectations Ahead Of Q3 Earnings Cardinal Health, Inc. (NYSE:CAH) will release its first quarter earnings report before the opening bell on Thursday, Nov. 5.
benzinga.com Top Wall Street Forecasters Revamp Cardinal Health Expectations Ahead Of Q1 Earnings Cardinal Health expects Q1 EPS of $2.94 and revenue of $66.51B. Analysts remain bullish, raising price targets up to $295.
benzinga.com Dow Jumps Over 1,500 Points After Midterms: Investor Sentiment Improves, Greed Index Moves To ‘Fear’ Zone CNN Fear & Greed rose to 27 in the Fear zone as U.S. stocks surged after Democrats won Congress; oil fell and most sectors gained.
benzinga.com Qualcomm, US Foods And 3 Stocks To Watch Heading Into Thursday Stocks in focus: Cardinal Health and US Foods report earnings; Qualcomm and Snap shares fall after results; Airbnb reports after the close.
benzinga.com Here's How Much $1000 Invested In Cardinal Health 5 Years Ago Would Be Worth Today Cardinal Health (NYSE:CAH) has outperformed the market over the past 5 years by 29.24% on an annualized basis producing an average annual return of 39.65%. Currently, Cardinal Health has a market…
benzinga.com Toyota, ConocoPhillips On Deck Thursday As Auto Demand, Oil Prices Face Test Toyota Motor headlines Thursday’s reports, with investors weighing the automaker’s earnings outlook against a stock still well below its 52-week high. ConocoPhillips, Sony Group, Parker Hannifin and…
zacks.com What Analyst Projections for Key Metrics Reveal About Cardinal (CAH) Q1 Earnings Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Cardinal (CAH), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the…
zacks.com Can CAH's Specialty Strength Offset Medical Distribution Challenges in Q1? Cardinal Health CAH is scheduled to report first-quarter fiscal 2027 results on Nov. 5, before the market opens. The company entered the quarter with strong pharmaceutical demand, expanding specialty…- benzinga.com Morgan Stanley Maintains Overweight on Cardinal Health, Raises Price Target to $286 Morgan Stanley analyst Erin Wright maintains Cardinal Health (NYSE:CAH) with a Overweight and raises the price target from $265 to $286.
benzinga.com Mizuho Maintains Outperform on Cardinal Health, Raises Price Target to $280 Mizuho analyst Steven Valiquette maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price target from $250 to $280.- benzinga.com UBS Maintains Buy on Cardinal Health, Raises Price Target to $295 UBS analyst Kevin Caliendo maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $280 to $295.
benzinga.com 10 Health Care Stocks With Whale Alerts In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
benzinga.com Cardinal Health, McKesson Double Down on CVS Deals Through 2032 Cardinal Health and McKesson extend drug distribution deals with CVS Health through June 2032, reaffirming FY2027 adjusted earnings guidance.- benzinga.com Cardinal Health Enters Into Binding LOI To Extend Existing Distribution Agreement With CVS Health Through June 30, 2032 Cardinal Health (NYSE:CAH) announced today that it has entered into a binding Letter of Intent to extend its existing distribution agreement with CVS Health through June 30, 2032, reflecting the…
benzinga.com 9 Health Care Stocks Whale Activity In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…- benzinga.com RBC Capital Initiates Coverage On Cardinal Health with Outperform Rating, Announces Price Target of $276 RBC Capital analyst Ryan Halsted initiates coverage on Cardinal Health (NYSE:CAH) with a Outperform rating and announces Price Target of $276.
- benzinga.com TD Cowen Maintains Buy on Cardinal Health, Raises Price Target to $280 TD Cowen analyst Charles Rhyee maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $275 to $280.
- benzinga.com JP Morgan Maintains Neutral on Cardinal Health, Raises Price Target to $260 JP Morgan analyst Lisa Gill maintains Cardinal Health (NYSE:CAH) with a Neutral and raises the price target from $215 to $260.
- benzinga.com Barclays Maintains Overweight on Cardinal Health, Raises Price Target to $275 Barclays analyst Glen Santangelo maintains Cardinal Health (NYSE:CAH) with a Overweight and raises the price target from $258 to $275.
- benzinga.com Evercore ISI Group Maintains Outperform on Cardinal Health, Raises Price Target to $270 Evercore ISI Group analyst Elizabeth Anderson maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price target from $265 to $270.
- benzinga.com Morgan Stanley Maintains Overweight on Cardinal Health, Raises Price Target to $265 Morgan Stanley analyst Erin Wright maintains Cardinal Health (NYSE:CAH) with a Overweight and raises the price target from $255 to $265.
benzinga.com Mizuho Maintains Outperform on Cardinal Health, Raises Price Target to $250 Mizuho analyst Steven Valiquette maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price target from $240 to $250.- benzinga.com UBS Maintains Buy on Cardinal Health, Raises Price Target to $280 UBS analyst Kevin Caliendo maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $274 to $280.
benzinga.com Cardinal Health Analysts Increase Their Forecasts Following Q4 Results Cardinal Health posted mixed Q4 results, with adjusted earnings of $2.91 per share beating estimates, but sales missing expectations. The company also raised its share repurchase authorization and…- benzinga.com Wells Fargo Maintains Overweight on Cardinal Health, Raises Price Target to $277 Wells Fargo analyst Stephen Baxter maintains Cardinal Health (NYSE:CAH) with a Overweight and raises the price target from $245 to $277.
- benzinga.com Baird Maintains Outperform on Cardinal Health, Raises Price Target to $274 Baird analyst Eric Coldwell maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price target from $251 to $274.
benzinga.com S&P 500 Falls for Second Session Ahead of Inflation Report: Investor Sentiment Weakens, Fear & Greed Index Remains in ‘Greed’ Zone CNN Fear & Greed Index: Market sentiment declined, but remained in Greed zone on Tuesday. Stocks closed lower.
benzinga.com Cardinal Health Says It Now Exclusively Serves Nearly Half The Cell-And-Gene Therapy Market CAH stock hits new 52-week high as Cardinal Health beats Q4 earnings, boosts FY27 outlook, and approves a $5B buyback expansion.
benzinga.com US Stocks Mixed; Cardinal Health Shares Jump After Q4 Results US stocks mixed, Dow up 150 points. Industrials gain 1%, communication services fall 1.1%. Cardinal Health (NYSE: CAH) up 8%. Oil up 0.4%, gold up 0.6%.- benzinga.com Cardinal Health Announces $5B Incremental Share Buyback Authorization Cardinal Health recently completed an additional $350 million accelerated share repurchase program, bringing year-to-date share repurchases in fiscal year 2026 to $1.4 billion.Cardinal Health Board…
benzinga.com Dow Falls Over 50 Points Ahead of Inflation Data: Fear Index Remains in ‘Greed’ Zone Stocks closed mostly lower on Monday, with the Fear and Greed index remaining in Greed zone. Investors await earnings results and CPI report.
benzinga.com Cardinal Health, Babcock & Wilcox Enterprises and 3 Stocks to Watch Heading Into Tuesday U.S. stock futures mixed, focus on Super Micro Computer Inc, Upwork Inc, Cardinal Health Inc, Babcock & Wilcox Enterprises Inc.- benzinga.com Cardinal Health Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts CAH to release Q4 earnings on Aug. 11, analysts expect EPS of $2.42 and revenue of $65.11B. Recently acquired diabetes health business for $360M.
benzinga.com Lumentum Could Swing $9.74 Billion After Earnings Earnings set to hit the tape Tues. Options market implying post-print swings for 5 stocks, from healthcare to AI. Cardinal Health has biggest move at 6.83%.- benzinga.com Citigroup Maintains Buy on Cardinal Health, Raises Price Target to $265 Citigroup analyst Daniel Grosslight maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $245 to $265.
benzinga.com Mizuho Maintains Outperform on Cardinal Health, Raises Price Target to $240 Mizuho analyst Steven Valiquette maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price target from $235 to $240.- benzinga.com Cardinal Health To Acquire The Diabetes Health Business Of Adapthealth And, In Its Entirety, Strive Medical For ~$360M In Cash Cardinal Health will acquire the Diabetes Health business of AdaptHealth Corp. (NASDAQ:AHCO), and, in its entirety, Strive Medical, a multi-specialty supply provider with a focus on urology.…
- benzinga.com AdaptHealth Divests Diabetes Health Business To Cardinal Health For $235M In Cash Continues the Company's multi-year effort to focus its portfolio on its core sleep, respiratory, and supporting home medical equipment businessesSharpens strategic focus on businesses where the…